AlphaFold predicted structure
TRPS1 · Q9UHF7

Mean pLDDT
48.5/ 100
Very low
1,281 residues
Confidence breakdown
- Very high(≥ 90)3%
- Confident(70–90)20%
- Low(50–70)9%
- Very low(< 50)68%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
transcriptional repressor GATA binding 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownLimb disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownSkeletal dysplasia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownOsteogenesis imperfecta
Trichorhinophalangeal syndrome type 1 and 3
trichorhinophalangeal syndrome type I
hereditary disease
Langer-Giedion syndrome
Hypercholesterolemia
Abnormality of the skeletal system
type 2 diabetes mellitus
trichorhinophalangeal syndrome type I or III
diverticular disease
metabolic disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Zinc finger transcription factor Trps1
Transcriptional repressor. Binds specifically to GATA sequences and represses expression of GATA-regulated genes at selected sites and stages in vertebrate development. Regulates chondrocyte proliferation and differentiation. Executes multiple functions in proliferating chondrocytes, expanding the region of distal chondrocytes, activating proliferation in columnar cells and supporting the differentiation of columnar into hypertrophic chondrocytes
TRPS1 · Q9UHF7

Mean pLDDT
48.5/ 100
Very low
1,281 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0